Rhodopsin is trafficked to the rod outer segment of vertebrate rod cells with high fidelity. When rhodopsin transport is disrupted retinal photoreceptors apoptose, resulting in the blinding disease autosomal dominant retinitis pigmentosa. Herein, we introduce rhodopsin-photoactivatable GFP-1D4 (rhodopsinpaGFP-1D4) for the purposes of monitoring rhodopsin transport in living cells. Rhodopsin-paGFP-1D4 contains photoactivatable GFP (paGFP) fused to rhodopsin's C-terminus and the last eight amino acids of rhodopsin (1D4) appended to the C-terminus of paGFP. The fusion protein binds the chromophore 11-cis retinal and photoisomerizes upon light activation similarly to rhodopsin. It activates the G-protein transducin with similar kinetics as does rhodopsin. Rhodopsin-paGFP-1D4 localizes to the same compartments, the primary cilium in cultured IMCD cells and the outer segment of rod cells, as rhodopsin in vitro and in vivo. This enables its use as a model of rhodopsin transport and details the importance of a free rhodopsin C-terminus in rod cell localization and health.
Introduction
G-protein coupled receptors (GPCRs) are a diverse family of receptors that initiate signaling cascades controlling slow neurotransmission, sight, smell, and taste. Due to the diverse roles of the some 800 known GPCRs in cell signaling processes and disease, more than one third of all medical drugs target GPCRs (Millar & Newton, 2010; Overington, Al-Lazikani, & Hopkins, 2006) . A major question that remains is how these receptors are trafficked to their site of function.
Rod photoreceptors offer an advantageous system to study GPCR trafficking through the movement of the GPCR rhodopsin after synthesis in rod cells. Rhodopsin functions in the rod outer segment (ROS) of these highly polarized neurons by interacting with photons of light, as well as other signaling proteins involved in the phototransduction cascade. The ROS is segregated from the rest of the rod cell by the connecting cilium and can be compared to the primary ciliary compartment in ciliated cells, though it is more specialized for phototransduction cascade instead of other signaling cascades. Rhodopsin is the most abundant protein in the ROS at a 3 mM or higher concentration, but is almost undetectable in either the synaptic terminus, the opposite end of the cell, or the inner segment, where approximately 10 7 molecules of the receptor per cell are synthesized daily in mice (Palczewski, 2012) . The fact that rhodopsin is barely detectable in the rod inner segment could be thought of as an obstacle to monitoring its transport with the commonly used EGFP/FRAP techniques. However, this obstacle can be overcome with the use of a photoactivatable GFP (paGFP) instead of EGFP. Photoactivating paGFP instead of photobleaching EGFP provides a bright spot on a dark background instead of a dark spot on a bright background. The role of rhodopsin's carboxy-terminal domain (C-terminus) in rhodopsin transport and localization was first suggested by transgenic animal studies. Collectively these studies demonstrate that mice with transgenes encoding rhodopsin mutants Q344ter or P347S, and transgenic rats with S334ter rhodopsin are prone to extensive mislocalization of rhodopsin to the plasma membrane of the inner segments (Li et al., 1996; Sung et al., 1994) . Antibody labeling for different rhodopsin variants reveals that the mislocalized proteins are mutant rhodopsins, while WT rhodopsin predominantly localizes properly to the ROS. These same mutations cause autosomal dominant retinitis pigmentosa, degeneration of photoreceptors that leads to blindness, in human patients (Dryja et al., 1990 (Dryja et al., , 1991 . Recent studies with the hRhoG knock-in mice expressing EGFP fused to rhodopsin's C-terminus show that obstruction of the C-terminus by EGFP causes recessive retinal degeneration in homozygous knock-in mice due to malformed disks in the ROS, even though function and apical localization appear normal (Gross et al., 2006; Wensel et al., 2005) . The hRhoG heterozygous mouse retinas expressing rhodopsin and rho-EGFP do not degenerate and rho-EGFP localization appears similar to rhodopsin localization, implying rhodopsin helps rho-EGFP enter the ROS thereby demonstrating the recessive nature of rho-EGFP induced retina degeneration in mice. Though some rhodopsin-EGFP mislocalization can be seen, it is to a lesser degree than is observed in the rhodopsin trafficking mutants and is not believed to be the cause of retinal degeneration in these mice due to the grossly malformed outer segments.
Photoreceptors do not properly polarize in culture (Saga, Scheurer, & Adler, 1996; Stenkamp & Adler, 1993) so immortalized ciliated cells have been useful for characterization studies in dissociated culture. In polarized Madin-Darby Canine Kidney (MDCK) cells, a multi-ciliated cell line, rhodopsin has been shown to localize apically, the location where cilia are found in polarized ciliated cells (Chuang & Sung, 1998) . Mouse inner medullary collecting duct (IMCD) cells are used in ciliary studies because they contain a single cilium per cell at the apical end of the polarized cell (Rauchman et al., 1993) . In this study, we characterize the synthetic rhodopsin fusion protein, rhodopsin-paGFP-1D4 (Fig. 1) , for use in rhodopsin trafficking studies. The fusion protein has a photoactivatable green fluorescent protein (paGFP) appended to the C-terminus of rhodopsin (Pedelacq et al., 2006; Ruta et al., 2010) . To gain more insight on the effects of obstructing the rhodopsin C-terminus, rhodopsin-paGFP-1D4 has the last eight amino acids of rhodopsin added to the C-terminus of paGFP. We report the ability of rhodopsin-paGFP-1D4 to fold, photobleach, activate the G-protein transducin and localize to the cilium in IMCD cells and outer segment of rod cells for use in trafficking studies.
Material and methods

Generation of rhodopsin constructs
The pMT3-rhodopsin and pMT3-rhodopsin-EGFP-1D4 plasmids containing rhodopsin or EGFP fused to rhodopsin with the last eight amino acids of rhodopsin appended to the C-terminus of EGFP were obtained from Daniel Oprian (Jin, McKee, & Oprian, 2003) . Using a series of QuikChange Ò reactions with oligos from Invitrogen and Pfu enzyme (Stratagene), pMT3-rhodopsin-EGFP-1D4 was changed to pMT3-rhodopsin-paGFP-1D4 (Table 1) (Pedelacq et al., 2006; Ruta et al., 2010) . The cDNAs encoding rhodopsin and the fusion protein were subcloned into the pcDNA3.1+ vector (Invitrogen) between the EcoRI and NotI restriction sites for mammalian cell transfection purposes and into the pXOP0.8 vector (courtesy of Orson Moritz) for transgenic Xenopus laevis preparation. The pXOP0.8 vector contains 800 bp of the Xenopus opsin promoter (XOP) directly before the insertion site (Tam et al., 2006) . A recognition site for the I-SceI meganuclease was inserted at a PciI site approximately 60 base pairs from the beginning of the XOP region using cassette mutagenesis as previously described (Gross, Rao, & Oprian, 2003) .
Tissue culture
COS-7 cells were grown at 37°C, 5% CO 2 in DMEM supplemented with 100 U/mL/100 lg/mL penicillin/streptomycin, 2 mM L-glutamine, and 10% FBS. The cells were grown to 95% confluency on 150 mm petri dishes or on cover slips in twelve well plates and transfected with the pMT3 constructs using the DEAE-Dextran method as per (Zeitz et al., 2008) . Transfected cells were harvested 72 h post-transfection for maximum protein expression.
IMCD cells were grown at 37°C, 5% CO 2 in DMEM supplemented 1:1 with Hamm's F-12, 100 U/mL/100 lg/mL penicillin/ streptomycin, 2 mM L-glutamine, and 10% FBS. Cells were transfected with either pMT3 or pcDNA3.1+ constructs for transient (high expression) or stable (low expression) transfections respectively via electroporation. Transiently transfected cells were grown for 24 h and polarized for an additional 24 h after transfection. Stably transfected cells were grown for 7 days in DMEM media with 50 ng/mL G418 to select for construct integration. Individual colonies were isolated and immunocytochemistry performed to select colonies expressing adequate amounts of protein. Cells were polarized on 0.4 lm pore filters and/or through serum starvation.
Protein purification and spectroscopy
The rhodopsins were purified from COS-7 cells as previously published (Jin, McKee, & Oprian, 2003) . Briefly, under dim red light at 4°C, 20 lM 11-cis retinal was added to the cell suspension to reconstitute the pigments. The cells were solubilized, centrifuged and the supernatant incubated with 1D4-conjugated Sepharose 4B immunoaffinity matrix (Oprian et al., 1987) . The beads were washed free of non-binding proteins and rhodopsin was eluted via competition using an excess of 1D4 peptide (TETSQVAPA).
Purified rhodopsins were subjected to UV-Visible (UV-Vis) spectrophotometry from 700 nm to 250 nm on a Cary-Varian 50 spectrophotometer adapted for dark room use. Data were acquired and processed using Microsoft Office Excel (for PC, versions 11.8313.8221 SP3, 12.0.6504.5000 SP2, and 14.0.6129.5000 (64-bit)) and Origin (Origin Lab, version 8.5.1). Rhodopsin concentration was calculated using a rhodopsin extinction coefficient of 42,700 M À1 cm À1 at 500 nm (Zvyaga et al., 1996) .
Transducin activation
Transducin was purified from bovine rod outer segments using DEAE-Cellulose ion exchange column and reactions were as previously outlined (Sammons & Gross, 2012) . Briefly, the ability of the rhodopsins to catalyze the exchange of [
35 S] GTPcS for bound GDP in the G-protein transducin was detected with aid of a filter-binding assay. Time points were taken every minute with light exposure at 6 min 30 s. The assays were performed with purified rhodopsins at a concentration of 5 nM. Reaction mixtures contained 10 mM BTP buffer (pH 6.7) containing 150 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 1 mM EDTA, 1 mM dithiothreitol, 75 nM transducin and 75 lM GTP c 35 S (100 lCi/mol). Reactions were initiated with the addition of [ 35 S] GTP c S in the dark.
Generation of transgenic animals
Transgenic X. laevis were generated using the I-SceI meganuclease method at 18°C as described by Ogino, McConnell, and Grainger (2006) with modifications. After inducing ovulation with human chorionic gonadotropin, the frogs were allowed to lay eggs in egg-laying buffer (ELB) (110 mM NaCl, 2 mM KCl, 0.6 mM Na 2-HPO 4 , 15 mM Tris-Acetate, pH 7.6, 2 mM NaHCO 3 , 2.1 mM MgSO 4 ). X. laevis eggs were collected and washed in 1X Modified Barth's Saline prior to dejellying. The fertilized eggs were injected with pXOP0.8-rhodopsin-paGFP-1D4 and I-SceI enzyme and allowed to divide. Embryos dividing to the 4-cell stage were isolated and allowed to develop at 18°C in 0.1Â MMR buffer (10 mM NaCl, 200 lM KCl, 100 lM MgSO 4 , 200 lM CaCl 2 , 500 lM HEPES pH 7.4). After one week tadpoles were moved to frog water (distilled water containing 1 g/L Marineland Ò Instant Ocean) for an additional week. Surviving tadpoles were euthanized with 0.2% tricaine and their eyes enucleated to determine transgenic protein localization. All animal studies were performed in accordance with approved IACUC protocols.
Protein localization
Transfected cells were fixed in 4% paraformaldahyde in phosphate buffered saline (PBS), pH 7.4 for 10 min at RT. The cells were permeabilized using methanol-acetone (50:50) for 5 min, blocked in 10% goat serum for 30 min, and probed for rhodopsin and acetylated a-tubulin using 1:2000 rhodopsin B630N antibody against the rhodopsin amino-terminus (N-terminus) or 1:1000 6-11B-1 antibody against acetylated a-tubulin for 2 h. After washing with PBS, 1:500 goat-anti-mouse IgG 1 secondary conjugated to AF488 or 1:500 goat-anti-mouse IgG 2b secondary conjugated to AF568 were used to label B630 and 6-11B-1 respectively. DAPI was used to label nuclei. Tissue was washed with PBS and mounted using Life Technologies Prolong Gold Ò anti-fade reagent. Fluorescence microscopy was then performed using a Zeiss LSM 710 laser scanning or Olympus IX81 spinning disk confocal microscope. COS-7 cells were imaged on the IX81 spinning disk with a 405 nm diode laser manually moved to photoactivate the paGFP thereby leaving gaps in the activated paGFP protein.
Eyes from 2-week old transgenic X. laevis were harvested posteuthanasia, fixed in 4% paraformaldahyde in PBS pH 7.4 overnight at 4°C, cryoprotected in 30% sucrose in 1X PBS for 2 h at 4°C, frozen in optimal cutting temperature medium (OCT) and sectioned to 12 lm slices. OCT was washed off the sections with 1X PBS pH 7.4. All tissue was permeabilized using methanol-acetone (50:50) for 5 min, blocked in 10% goat serum for 30 min, and probed for bovine rhodopsin using 1:1000 rhodopsin 1D4 antibody against the rhodopsin C-terminus for 2 h. 1:500 goat-anti-mouse IgG secondary conjugated to AF568 was used to label 1D4. DAPI was used to label nuclei. Tissue was washed free of the secondary antibodies and mounted using Prolong Gold Anti-fade Reagent. Fluorescence microscopy was then performed using an Olympus IX81 spinning disk confocal microscope to monitor rhodopsin localization.
Results
Fusion protein folding
Spectral analysis of rhodopsin in rho-paGFP-1D4
It was previously established that EGFP tagged rhodopsin is trafficked apically in mouse rods, however, there are morphological defects in the rod cells causing retinal degeneration in homozygous knock-in mice (Gross et al., 2006) . Hypothesizing this to be the result of obstruction of the C-terminal VXPX sorting motif, we have attached the last eight amino acids of rhodopsin, containing the VXPX COOH motif, to the end of GFP and used a photoactivatable version of GFP for use in monitoring rhodopsin transport (Jin, McKee, & Oprian, 2003) . To ensure no folding abnormalities were caused by the fusion, the UV-Vis spectrum of rhodopsin-paGFP-1D4 was compared to rhodopsin (Fig. 2) . Rhodopsin-paGFP-1D4 has an absorption peak at 397 nm generated by paGFP, not present in rhodopsin (Patterson & Lippincott-Schwartz, 2002) . The difference spectra of rhodopsin and rhodopsin-paGFP-1D4, determined by subtracting the light spectrum from the dark spectrum, appeared similar with a peak at 500 nm and a trough at 380 nm, indicating that the fusion protein folds correctly, binds 11-cis retinal, and photobleaches with light.
Ability of paGFP-1D4 to photoactivate
To monitor the ability of paGFP-1D4 to activate in the fusion protein, we transfected COS-7 cells and looked for the ability of rho-paGFP-1D4 to photoactivate in the cell (Fig. 3) . Pre-activation, there is minimal paGFP fluorescence, but after activation with 405 nm light, paGFP fluorescence is markedly increased. The fluorescence coincides with rhodopsin labeling, indicating the fluorescence is due to photoactivation of the fusion protein.
Transducin activation
Rhodopsin's 3rd intracellular (i3) loop binds transducin, rhodopsin's G-protein, and thus plays an important role in activating transducin (Janz & Farrens, 2004) . We performed assays to test the light-dependent activation of transducin by rhodopsinpaGFP-1D4 to determine if addition of the 30 kD paGFP affects transducin activation by inhibition of transducin binding to rhodopsin's i3 loop. Rhodopsin-paGFP-1D4 activates transducin with comparable kinetics to that of rhodopsin under the same (Fig. 4) . In the dark, rhodopsin activates transducin minimally, but after light exposure, there is a marked uptake of [ 35 S] GTPcS, an indicator that the active rhodopsin fusion protein activates transducin despite the presence of the photoactivatable GFP-1D4 moiety.
Rhodopsin localization
As the paGFP-1D4 contains the VXPX sorting motif known to target proteins to the cilium instead of to the plasma membrane, we aimed to determine rhodopsin's localization within polarized monociliated mouse IMCD cells as well as in transgenic X. laevis (Concepcion, Mendez, & Chen, 2002; Tam et al., 2000) . We first expressed rhodopsin and rhodopsin-paGFP-1D4 transiently at high expression levels to mimic the high expression seen in rod cells. Rhodopsin-paGFP-1D4 localizes to the apical end of IMCD cells similarly to rhodopsin (Fig. 5A-F) . Two possibilities exist for these proteins localizing to the apical end of the cells instead of solely to the cilium. The first is that there such a high quantity of rhodopsin being expressed that it overflows the cilium into the apical end of the cell as it is trafficked to the cilium. The second possibility is that the trafficking machinery is overloaded and a large portion of the protein is mislocalized to the apical end of the cell. In either case, reducing the amount of rhodopsin being expressed would reduce the amount of rhodopsin outside the cilium if properly localized. As such, we generated IMCD cells stably expressing rhodopsin or rhodopsin-paGFP-1D4, induced polarization, and monitored for protein localization. We observed that when expressed at lower quantities both rhodopsin and rhodopsin-paGFP-1D4 localized solely to the cilium of these cells indicating that at least one of the VXPX sorting motifs was conformationally available for ciliary transport in the fusion protein (Fig. 5G-L) .
We generated transgenic X. laevis expressing rhodopsin-paGFP-1D4 under the Xenopus opsin promoter to determine the localization of the synthetic protein in its natural environment. Similar to rhodopsin, rhodopsin-paGFP-1D4 localizes to the ROS Fig. 2 . Photoconversion of rhodopsin. UV-Visible absorbance spectra were performed on purified reconstituted rhodopsin (left) and rhodopsin-paGFP-1D4 (right). Spectra were taken in the dark (dotted line, dark) and after photo-activation (dashed line, light). The difference between the two (solid line, diff) shows photo-conversion of inactive rhodopsin to active rhodopsin. Photoactivatable-GFP (double line, paGFP) absorbs maximally at 400 nm and can be observed in the rhodopsin-paGFP-1D4 spectra. The similarity in the difference spectra between rhodopsin and rhodopsin-paGFP-1D4 indicates that rhodopsin-paGFP-1D4 photo-converts properly. Spectra were normalized to the 500 nm absorbance peak of dark rhodopsin. Fig. 3 . Photoactivation of paGFP in COS-7 cells. COS-7 cells were transfected with pMT3-rho-paGFP-1D4 and immunolabelled for rhodopsin. Minimal paGFP fluorescence was observed prior to photoactivation (A and B, green). However, after paGFP was photoactivated using 405 nm, paGFP fluorescence observed (C and D, green) . The change in fluorescence of paGFP indicates it ability to be photoactivated. Rhodopsin labeling is overlaid to show the photoactivated protein is rho-paGFP-1D4 (B and D, red). DAPI, blue; scale bar, 50 lm.
in transgenic X. laevis (Fig. 6) . We saw no indications of retinal degeneration or mislocalization in these transgenic animals (n = 15).
Discussion
We have generated photoactivatable GFP fused to rhodopsin to monitor rhodopsin movement, a key aspect yet to be explained with GPCRs. To include a C-terminal rhodopsin sorting motif, we have attached a repeat of the last eight amino acids of rhodopsin to the C-terminus of paGFP generating rhodopsin-paGFP-1D4. We have shown that fusion of paGFP-1D4 to rhodopsin's C-terminus does not inhibit rhodopsin activation and that the difference spectrum of rhodopsin-paGFP-1D4 looks similar to the rhodopsin difference spectrum. We also showed that the protein functions correctly in its activation of transducin, signifying no significant difference in function despite the addition of a $30 kD protein to rhodopsin's C-terminus.
We next sought to identify the cellular localization of the fluorescent fusion protein in polarized cells and showed that the protein localizes correctly to the cilium of IMCD cells. This answered a major question of whether the fusion protein could be properly transported to the organelle without the help of endogenously expressed rhodopsin; that the VXPX sorting motif is still functional in targeting the protein to the cilium in vitro. However, rod cells have a specialized ciliary organelle, the rod outer segment. In rod cells, the added step of inserting rhodopsin into disks is present and it has been shown that rho-EGFP cannot properly perform this task without the help of rhodopsin even though the majority of rho-EGFP localize apically (toward the cilium) in homozygous retinas (Wensel et al., 2005) . To monitor the localization of the fusion protein in vivo, we prepared transgenic X. laevis. Rhodopsin-paGFP-1D4 localized correctly to the ROS in the transgenic rods similar to Jin, McKee, and Oprian (2003) . A caveat to using dissociated culture is that the protein is not in its native environment and a caveat to using transgenic animals is the presence of endogenous rhodopsin possibly helping transport. However, combined, these data suggest that in its native environment without the presence of endogenous rhodopsin, the fusion protein should localize similarly to rhodopsin. With the addition of the VXPX COOH sorting motif to the fusion protein's C-terminus, the rhodopsin-paGFP-1D4 may also rescue the abnormal disk and morphologies phenotype observed in the hRhoG knock-in mouse (Gross et al., 2006) .
Instead of using a constitutively fluorescing protein fused to rhodopsin to monitor trafficking, using a photoactivatable version of the fluorophore enables us to monitor the presence of a bright Fig. 4 . Rhodopsin-paGFP-1D4 activates transducin. Assay testing for transducin activation. Transducin activation by rhodopsin (grey diamonds) or rhodopsinpaGFP-1D4 (black squares) was performed. Six time points were taken prerhodopsin activation (filled markers), exposed to bright white light (hv), and six more time points taken post-rhodopsin activation (unfilled markers). RhodopsinpaGFP-1D4 activates transducin with similar kinetic rates as rhodopsin with no significant difference between the maximum activation rates. respectively, were probed with acetylated a-tubulin (red) to label the cilium, imaged with confocal microscopy and reconstructed in the X-Z plane to monitor ciliary localization. Rhodopsin was also probed with the rhodopsin N-terminal antibody B6-30N (green) while paGFP on rhodopsin-paGFP-1D4 was photoactivated (green). All nuclei were labeled with DAPI (blue). Rhodopsin and rhodopsin-paGFP-1D4 localized to the apical end of the polarized cells, partially co-localizing with the cilium in the transiently transfected cells and solely to the cilium in stably transfected cells (orange). Scale bar, 10 lm.
green fluorescent spot on a dark background after photoactivation, thereby improving the optical ability of photodetection. Instead of trying to detect a dark spot in a bright green background, as with FRAP studies on rhodopsin-EGFP (Trivedi et al., 2012) or color change upon activation (Lodowski et al., 2013) , the rho-paGFP-1D4 transgenic animals are more easily detectible and thereby may improve spatial kinetic measurements in a living retina. By using a photoactivatable GFP instead of constitutively active GFP, we do not limit ourselves to monitoring only the region that we photobleached. Additionally, the photo-switchable fluorescent protein must use two channels to monitor fluorescent changes in the entire cell. Here, a single channel can be used to monitor fluorescent changes inside and outside of the photoactivated region thereby providing a more simple and comprehensive method of monitoring rhodopsin and GPCR transport.
In summary, we have generated a rhodopsin-paGFP-1D4 fusion to be used as a tool to monitor rhodopsin transport. We have shown that it functions and localizes similarly to rhodopsin in vitro and in vivo and propose its use for trafficking studies.
